Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

CONCORD HOSPITAL-LACONIA

NPI: 1619053618 · LACONIA, NH 03246 · Medicare Defined Swing Bed Hospital Unit · NPI assigned 10/31/2006

$2.92M
Total Medicaid Paid
111,315
Total Claims
80,033
Beneficiaries
163
Codes Billed
2021-05
First Month
2024-11
Last Month

Provider Details

Authorized OfficialSLOANE, SCOTT (CHIEF FINANCIAL OFFICER)
Parent OrganizationCONCORD HOSPITAL-LACONIA
NPI Enumeration Date10/31/2006

Related Entities

Other providers sharing the same authorized official: SLOANE, SCOTT

ProviderCityStateTotal Paid
CONCORD HOSPITAL, INC. CONCORD NH $28.77M
CONCORD HOSPITAL-LACONIA LACONIA NH $9.25M
CONCORD HOSPITAL-FRANKLIN FRANKLIN NH $7.28M
CONCORD HOSPITAL, INC. CONCORD NH $3.74M
CONCORD HOSPITAL-FRANKLIN FRANKLIN NH $3.61M
CONCORD HOSPITAL-FRANKLIN FRANKLIN NH $2.72M
CONCORD HOSPITAL-LACONIA LACONIA NH $2.53M
CONCORD HOSPITAL, INC. CONCORD NH $2.48M
CONCORD HOSPITAL-LACONIA LACONIA NH $109K
CONCORD HOSPITAL-LACONIA LACONIA NH $16K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2021 61,483 $1.96M
2022 28,406 $756K
2023 13,211 $132K
2024 8,215 $81K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99284 Emergency department visit for the evaluation and management, high severity 3,156 2,536 $507K
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 2,410 1,907 $439K
99283 Emergency department visit for the evaluation and management, moderate severity 3,064 2,495 $424K
74177 Computed tomography, abdomen and pelvis; with contrast material 776 666 $136K
G0378 Hospital observation service, per hour 433 173 $125K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 9,102 6,667 $90K
71275 Computed tomographic angiography, chest, with contrast material 218 185 $78K
70450 Computed tomography, head or brain; without contrast material 640 513 $66K
99282 Emergency department visit for the evaluation and management, low to moderate severity 673 546 $55K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 217 177 $55K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1,548 1,171 $52K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 741 604 $50K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 2,571 726 $45K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 2,942 2,294 $39K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 912 604 $35K
96361 Intravenous infusion, hydration; each additional hour 1,882 1,411 $35K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 2,186 1,695 $29K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 1,748 1,405 $28K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 810 634 $28K
72125 Computed tomography, cervical spine; without contrast material 212 152 $27K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 711 546 $27K
96375 Therapeutic injection; each additional sequential IV push 1,364 1,003 $26K
80050 General health panel 3,478 2,837 $25K
J3490 Unclassified drugs 5,690 1,958 $24K
71045 Radiologic examination, chest; single view 1,821 1,453 $23K
77067 Screening mammography, bilateral, including computer-aided detection 233 207 $22K
76830 Ultrasound, transvaginal 265 215 $20K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 197 167 $15K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 469 338 $13K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 307 166 $13K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 536 472 $12K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 536 472 $12K
88305 Level IV - Surgical pathology, gross and microscopic examination 307 251 $11K
76705 Ultrasound, abdominal, real time with image documentation; limited 148 118 $11K
45384 16 12 $11K
71260 Computed tomography, thorax, diagnostic; with contrast material 53 45 $10K
96376 382 231 $10K
71046 Radiologic examination, chest; 2 views 687 559 $10K
93971 124 109 $10K
J7030 Infusion, normal saline solution , 1000 cc 1,447 1,153 $9K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 13 13 $9K
84484 2,295 1,511 $8K
80061 Lipid panel 943 816 $8K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 1,330 1,185 $8K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 865 606 $7K
72148 Magnetic resonance imaging, lumbar spine; without contrast material 34 28 $7K
97161 131 108 $7K
74176 Computed tomography, abdomen and pelvis; without contrast material 50 41 $7K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 644 165 $6K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up 120 101 $6K
G0145 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision 271 223 $6K
80053 Comprehensive metabolic panel 3,792 2,947 $6K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 4,220 3,100 $6K
J2704 Injection, propofol, 10 mg 687 481 $5K
83690 1,459 1,174 $5K
97162 136 105 $5K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination 313 94 $5K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 234 193 $5K
94060 108 89 $5K
87086 Culture, bacterial; quantitative colony count, urine 1,536 1,226 $5K
J3010 Injection, fentanyl citrate, 0.1 mg 600 410 $5K
83036 Hemoglobin; glycosylated (A1C) 979 850 $4K
J7120 Ringers lactate infusion, up to 1000 cc 545 380 $4K
83880 224 190 $4K
84443 Thyroid stimulating hormone (TSH) 673 568 $4K
97035 437 137 $4K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 179 153 $4K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 152 111 $4K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 544 234 $4K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring 56 50 $3K
80048 Basic metabolic panel (calcium, ionized) 813 562 $3K
82947 711 360 $3K
83735 1,039 788 $3K
84702 229 170 $3K
87077 581 466 $3K
87186 520 413 $3K
87040 451 207 $3K
97803 198 148 $3K
82728 242 202 $3K
84703 458 380 $3K
74018 129 103 $2K
83605 444 314 $2K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 91 79 $2K
J7060 5% dextrose/water (500 ml = 1 unit) 308 189 $2K
81001 1,474 1,166 $2K
J7050 Infusion, normal saline solution, 250 cc 262 172 $2K
J1170 Injection, hydromorphone, up to 4 mg 275 156 $2K
81025 434 342 $2K
72100 91 68 $2K
36415 Collection of venous blood by venipuncture 6,538 4,838 $2K
85379 283 245 $2K
85610 1,567 935 $2K
77063 Screening digital breast tomosynthesis, bilateral 231 205 $2K
86140 583 444 $2K
82805 114 83 $2K
97165 34 28 $2K
86803 162 133 $2K
84439 223 199 $2K
J0696 Injection, ceftriaxone sodium, per 250 mg 268 155 $1K
94729 90 74 $1K
J1885 Injection, ketorolac tromethamine, per 15 mg 1,536 1,171 $1K
J0690 Injection, cefazolin sodium, 500 mg 226 135 $1K
J2405 Injection, ondansetron hydrochloride, per 1 mg 1,391 1,021 $1K
73630 58 45 $1K
J2250 Injection, midazolam hydrochloride, per 1 mg 385 282 $1K
J2270 Injection, morphine sulfate, up to 10 mg 274 203 $1K
73610 57 50 $1K
94726 37 29 $1K
76801 18 13 $1K
86850 129 104 $979.53
73130 51 40 $968.93
73030 29 27 $938.42
87081 196 167 $927.91
87088 313 245 $921.71
Q3014 Telehealth originating site facility fee 306 201 $856.04
81003 1,402 1,170 $831.67
86618 75 60 $804.11
85652 473 352 $792.68
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 30 26 $782.58
87070 109 89 $718.33
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 46 16 $702.11
J1100 Injection, dexamethasone sodium phosphate, 1 mg 416 298 $686.57
80305 852 708 $670.65
82607 71 59 $654.89
J1610 Injection, glucagon hydrochloride, per 1 mg 16 13 $622.62
99281 Emergency department visit for the evaluation and management, self-limited or minor 17 13 $561.36
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 709 500 $536.91
82375 114 83 $500.92
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 95 64 $499.75
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 338 240 $496.76
87205 161 132 $490.53
87807 52 42 $474.80
A9576 Injection, gadoteridol, (prohance multipack), per ml 53 38 $444.87
85027 140 124 $419.42
85730 113 91 $387.72
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 202 163 $309.15
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 33 27 $280.08
J2060 Injection, lorazepam, 2 mg 228 164 $274.95
83550 34 30 $274.37
84153 24 24 $271.50
96367 14 12 $255.83
36416 606 457 $252.11
86900 134 101 $250.00
A9270 Non-covered item or service 1,413 670 $242.20
86901 134 101 $223.26
83540 36 32 $215.47
82550 54 47 $204.76
86592 65 55 $196.89
J1200 Injection, diphenhydramine hcl, up to 50 mg 146 113 $188.27
82950 41 38 $170.82
86038 19 13 $146.53
J0780 Injection, prochlorperazine, up to 10 mg 29 25 $144.76
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 39 32 $134.69
J3480 Injection, potassium chloride, per 2 meq 13 12 $119.25
J0131 Injection, acetaminophen, not otherwise specified,10 mg 15 12 $119.09
84100 33 25 $102.22
87147 15 12 $96.46
51798 19 13 $83.59
82043 16 13 $70.11
G0008 Administration of influenza virus vaccine 121 101 $49.95
90686 64 54 $35.70
84550 14 12 $30.20
Q0244 Injection, casirivimab and imdevimab, 1200 mg 41 38 $0.00